1. BioSpace. Gilead Suspends a Remdesivir COVID-19 Trial in China. https://www.biospace.com/article/gilead-shutters-covid-19-trial-in-china-stocks-drop-3-percent-/(accessed 2020 15th April).
2. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial;Wang;Lancet,2020
3. Disease NIoAaI. NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19. 2020. https://www.niaid.nih.gov/news-events/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19 (Accessed 5 May 2020).
4. Administration FaD. Remdesivir EUA Letter of Authorization. 2020. https://www.fda.gov/media/137564/download (Accessed 5 May 2020).
5. News S. Inside the NIH's controversial decision to stop its big remdesivir study. 2020. https://www.statnews.com/2020/05/11/inside-the-nihs-controversial-decision-to-stop-its-big-remdesivir-study/(Accessed 10 May 2020).